Article Per Year (5 Year)
p-Index From 2021 - 2026
0.444
P-Index
This Author published in this journals
All Journal VISIKES Jurnal Farmasi
Yustisia Dian Advistasari
Sekolah Tinggi Ilmu Farmasi Yayasan Pharmasi Semarang
Dentistry Education Health Professions Medicine & Pharmacology Nursing Public Health

Published : 3 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search
Journal : visikes

 1 
Cost Of Illness Perawatan Pasien Gagal Ginjal Kronik Di Instalasi Rawat Inap Rsi Sultan Agung Semarang Wahyu Chandi Saputra; F.X Sulistiyanto W.S; Yustisia Dian Advistasari; Siti Munisih
VISIKES: Jurnal Kesehatan Masyarakat Vol 19, No 2 (2020)
Publisher : Dian Nuswantoro Semarang

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33633/visikes.v19i2.4196

Abstract

Gagal ginjal kronik didefinisikan sebagai kelainan struktur atau fungsi ginjal selama lebih dari 3 bulan yang berdampak bagi kesehatan. Pengobatan gagal ginjal kronik (GGK) membutuhkan biaya yang tidak sedikit karena membutuhkan waktu pengobatan jangka panjang dan sering timbul penyakit komorbid. Tujuan penelitian ini adalah untuk mengetahui total biaya yang harus dikeluarkan pasien gagal ginjal kronik selama dirawat. Analisis ini dilakukan dengan cara menghitung total biaya langsung yang harus dikeluarkan Tujuan penelitian ini adalah untuk mengetahui pengaruh karakteristik pasien terhadap biaya perawatan pasien gagal ginjal kronik dan untuk mengetahui total biaya medik langsung pada pasien GGK tanpa komorbid dan pasien GGK dengan komorbid di instalasi rawat inap RSI Sultan Agung Semarang Periode Januari–Agustus 2019 berdasarkan metode Cost Of Illness.Hasil penelitian ini terdapat 113 kasus gagal ginjal kronik. Berdasarkan uji statistika diperoleh hasil bahwa karakteristik pasien berdasarkan jenis kelamin, usia, dan penyakit komorbid tidak mempengaruhi total biaya medik langsung yang ditimbulkan pasien karena mempunyai nilai koefisien korelasi sangat lemah. Hasil total biaya medik langsung perawatan pasien gagal ginjal kronik pada pasien GGK tanpa komorbid sebesar Rp. 63.226.200, pasien GGK + diabetes mellitus sebesar Rp. 23.607.700, pasien GGK + hipertensi sebesar Rp. 57.859.600, pasien GGK + anemia sebesar Rp. 63.014.800, pasien GGK + hipoglikemia sebesar Rp. 2.265.000. Perbandingan total biaya medik langsung pada pasien GGK tanpa komorbid dan pasien GGK dengan komorbid terletak pada biaya pelayanan farmasi. Biaya pelayanan farmasi merupakan cost driven dari pasien GGK.Kata Kunci : Gagal Ginjal Kronik, Cost Of Illness, RSI Sultan Agung Semarang
Cost-Effectiveness of Antihypertensive Therapy in Ischemic Stroke Patients Rowiyah Sufi Nurul Janah; F.X. Sulistiyanto Wibowo S; Yustisia Dian Advistasari
VISIKES Vol. 25 No. 1 (2026): VISIKES
Publisher : Dian Nuswantoro Semarang

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.60074/visikes.v25i1.16101

Abstract

Ischemic stroke is an acute condition caused by the interruption of blood flow to the brain due to blood vessel obstruction, which can lead to permanent disability and death. Hypertension is a major risk factor and the most common comorbidity in ischemic stroke patients. The use of antihypertensive therapy in stroke patients plays a crucial role in controlling blood pressure and preventing complications, but it also increases the burden of medical costs. Therefore, a pharmacoeconomic evaluation is necessary to assess the cost-effectiveness of the therapy. This study aims to analyze patient characteristics and evaluate the cost-effectiveness of oral antihypertensive therapy in ischemic stroke patients at Hospital "X" from September 2024 to August 2025. The method used was Cost-Effectiveness Analysis (CEA) with the Average Cost-Effectiveness Ratio (ACER), in which the therapy with the lowest ACER is considered the most cost-effective. The results showed that the majority of patients were male (32 patients), and the largest age group was elderly aged 56–65 years (23 patients), with an average length of stay of 4.63 days. As a single therapy, calcium channel blockers (CCBs) demonstrated the lowest ACER value of Rp34,013.77, making them the most cost-effective therapy. In combination therapy, the combination of CCBs and beta-blockers had the lowest ACER value (Rp29,766.44). These results indicate that selecting the right antihypertensive therapy can improve cost efficiency and support more rational healthcare delivery.
Co-Authors Achmad Wildan Erlita Verdia Mutiara Erwin Indriyanti F.X Sulistiyanto W.S F.X. Sulistiyanto Wibowo S Rowiyah Sufi Nurul Janah Siti Munisih Wahyu Chandi Saputra